- The use of biochemical markers in cardiotoxicity monitoring in patien…
Number of the records: 1  

The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia

  1. TitleThe use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia / J.M. Horáček ... [et al.]
    Another responsib. Horáček, Jan M. (Author)
    Pudil, Radek, 1966- (Author)
    Tichý, Martin, 1943- (Author)
    Jebavý, Ladislav (Author)
    Štrasová, A. (Author)
    Praus, R. (Author)
    Žák, Pavel, 1966- (Author)
    Malý, Jaroslav, 1946- (Author)
    Translated titlePoužitie biochemických markerov pri monitorovaní kardiotoxicity u pacientov liečených na leukémiu
    Phys.des.Grafy, tab.
    NoteRes. angl.. Bibliogr. odkazy
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 52, no. 5 (2005), p. 430-434
    Call numberC 720
    MeSH Subject Burkittov lymfóm - diagnostika - farmakoterapia - komplikácie
    účinky liekov vedľajšie a nežiaduce reakcie liekov - komplikácie - etiológia
    biomarkery - analýza
    systematics616.155.392-085
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    Citations [*4] NAGY, A. Cs. - TOLNAY, E. - NAGYKÁLNAI, T. - FORSTER, T. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI. In Neoplasma : journal of experimental and clinical oncology. ISSN 0028-2685, 2006, vol. 53, no. 6, p. 511-517.
    [*1] CHOVANEC, Ján - CHOVANEC, Michal - MEGO, Michal. Levels of NT-proBNP and Troponin T in Cancer Patients - Mini-Review. In Klinická onkologie. - Praha : Ambit Media, 2020. ISSN 0862-495X, 2020, roč. 33, č. 3, s. 171-183.
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.